Abbott Laboratories
ABTToday
-0.44%
5 Days
+1.77%
1 Month
+12.39%
6 Months
-3.02%
Year to Date
-14.21%
1 Year
-17.91%
Recent
Analysis
Intuitive Surgical Inc Stock (ISRG) Closed Up by 5.71% on Jul 27: What Signal Does It Send?
• Intuitive Surgical exceeded quarterly expectations, raising full-year guidance on high global procedure volumes. • Strong Da Vinci 5 platform adoption and recurring revenue streams drove institutional investor confidence. • Technical indicators show a sell signal, despite positive fundamental growth and market positioning.
Stryker Corp Stock (SYK) Moved Down by 3.42% on Jul 17: A Full Analysis
• Stryker stock fell due to concerns regarding orthopedic demand and hospital capital spending. • Elevated treasury yields are compressing valuation multiples for high-growth medical technology firms. • Technical breaches of support levels and institutional profit-taking contributed to intraday price volatility.
Intuitive Surgical Inc Stock (ISRG) Moved Down by 12.39% on Jul 17: What Investors Need To Know
• Intuitive Surgical shares declined after missing second-quarter revenue and procedure volume expectations. • Management lowered 2026 procedure growth guidance due to slowing international elective surgery rates. • Increased R&D spending and rising costs compressed operating margins, triggering institutional selling.
Abbott Laboratories Stock (ABT) Moved Up by 3.03% on Jul 17: Drivers Behind the Movement
• Abbott Laboratories reported second-quarter earnings exceeding Wall Street expectations. • Management raised full-year earnings guidance due to strong organic sales growth. • Medical devices and nutrition segments drove overall financial performance and revenue growth.
Unitedhealth Group Inc Stock (UNH) Moved Up by 4.61% on Jul 16: Key Drivers Unveiled
• UnitedHealth’s second-quarter earnings beat Wall Street expectations on revenue and profit. • Management raised full-year earnings guidance, driving positive institutional investor sentiment and market rallies. • Disciplined Medical Care Ratio management mitigated investor concerns regarding rising healthcare utilization rates.
Abbott Laboratories Stock (ABT) Closed Down by 3.43% on Jul 14: A Full Analysis
• Abbott Laboratories shares declined due to litigation risks and medical device division concerns. • Legal proceedings regarding infant formula claims continue to negatively impact institutional sentiment. • Increased competition and pricing pressures contributed to analyst downward adjustments in growth estimates.
Abbott Laboratories's Score
Media Coverage
Analyst Rating
Abbott Laboratories Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Abbott Laboratories Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.48% |
| BlackRock Institutional Trust Company, N.A. | 5.33% |
| State Street Investment Management (US) | 4.58% |
| Capital International Investors | 3.63% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 47.22% |
| Investment Advisor/Hedge Fund | 23.05% |
| Research Firm | 3.28% |
| Pension Fund | 2.38% |
Related Instruments
Popular Instruments
